August 17, 2020
UC San Diego researchers discovered that tumor cells in younger and female patients accumulate cancer-causing mutations that are more poorly presented to the immune system, better enabling tumors to escape detection and clearance.
November 27, 2017
A team of University of California San Diego School of Medicine and Moores Cancer Center researchers studying new drugs designed to break resistance to cancer immunotherapy has been awarded a V Foundation for Cancer Research translational grant of $600,000 over three years.
October 11, 2023
University of California San Diego cancer biologist Tatiana Hurtado de Mendoza has been named the recipient of the 2023 Claugus Award for Medical Research. The award was established in 2021 by the Foundation For A Better World.
October 21, 2019
J. Silvio Gutkind elected to National Academy of Medicine for his contributions to the understanding of cancer signaling networks and pioneering the study of the PIK3CA-mTOR signaling circuitry in head and neck cancer.
January 20, 2017
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) has approved a pair of $2 million awards to University of California San Diego School of Medicine researchers to advance studies of new treatments for Zika virus infections and the use of stem cell-derived natural killer (NK)…
November 8, 2017
Chronic inflammation is known to drive many cancers, especially liver cancer. Researchers have long thought that’s because inflammation directly affects cancer cells, stimulating their division and protecting them from cell death. But University of California San Diego School of Medicine researchers have now found that chronic liver inflammation also promotes…
June 18, 2020
…UC San Diego’s groundbreaking immunotherapy research.” A blood and marrow transplant replaces damaged cells in patients whose normal blood cells have been crowded out by cancerous cells. BMT is often preceded by high-dose chemotherapy for blood cancers that include leukemia, lymphomas, myeloma and more. Patients are offered numerous treatment pathways…
March 27, 2023
Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health examined a new treatment approach for endometrial cancer.
December 1, 2016
Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role for these enzymes in subduing cancer immunity. The findings could have a clinical role in improving efficiency of immunotherapy drugs.
July 10, 2018
…help determine whether a cancer patient will respond to immunotherapy.
